Codes / ICD10CM / K51.411

K51.411 Inflammatory polyps of colon with rectal bleeding

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Inflammatory polyps of colon with rectal bleeding
  • Medical Term: Inflammatory Polyps of Colon with Rectal Bleeding

Summary

Inflammatory polyps of the colon with rectal bleeding are benign growths that develop in response to chronic inflammation in the colonic mucosa, accompanied by bleeding from the rectum. These polyps are not neoplastic and typically arise in areas of active or prior inflammation, such as in inflammatory bowel disease. The bleeding is a direct result of the polyps' inflammatory nature and potential ulceration.

Causes

The development of inflammatory polyps with rectal bleeding is linked to chronic inflammation in the colon, often resulting from conditions like ulcerative colitis or infectious colitis. The inflammation triggers a reparative response, leading to polyp formation, and the bleeding occurs when these polyps become irritated or ulcerated. They are not caused by genetic mutations associated with neoplastic polyps.

Risk Factors

  • Chronic inflammatory bowel disease (e.g., ulcerative colitis)
  • History of infectious colitis
  • Long-standing mucosal inflammation
  • Prior colon surgery or interventions
  • Use of nonsteroidal anti-inflammatory drugs (NSAIDs)

Symptoms

  • Rectal bleeding (bright red or dark blood in stool)
  • Asymptomatic in some cases
  • Altered bowel habits (e.g., diarrhea or constipation)
  • Abdominal discomfort or pain
  • Mucus in stool

Diagnosis

Diagnosis is typically made during colonoscopy, where polyps are visualized and biopsied. Histopathological examination confirms their inflammatory nature, and the presence of rectal bleeding is documented clinically. Additional tests, such as stool samples or imaging, may be used to rule out other causes of bleeding.

Treatment Options

  • Medications: Anti-inflammatory drugs (e.g., aminosalicylates) to reduce mucosal inflammation.
  • Endoscopic removal: Polypectomy to address bleeding or symptomatic polyps.
  • Management of underlying conditions: Treating the primary inflammatory bowel disease to prevent recurrence.
  • Monitoring: Regular colonoscopies to assess polyp status and bleeding risk.

Prognosis and Follow-Up

Prognosis is generally favorable, as inflammatory polyps are benign. However, ongoing bleeding or recurrence may require repeated interventions. Follow-up colonoscopies are recommended to monitor for new polyps or changes in the underlying inflammatory condition. Long-term management focuses on controlling the primary disease to reduce complications.

Complications

  • Persistent or severe rectal bleeding
  • Anemia from chronic blood loss
  • Obstruction if polyps become large
  • Increased risk of colorectal cancer in associated inflammatory bowel disease

Lifestyle & Prevention

  • Maintain a balanced diet to support gut health.
  • Avoid triggers for inflammatory bowel disease (e.g., certain foods or stress).
  • Quit smoking, as it may exacerbate inflammation.
  • Follow prescribed treatments for underlying conditions to reduce polyp formation.

When to Seek Professional Help

Seek immediate medical attention for:

  • Heavy or persistent rectal bleeding.
  • Dizziness, fatigue, or signs of anemia.
  • Severe abdominal pain or changes in bowel habits.
  • Unexplained weight loss or fever.

Tips for Medical Coders

Document the presence of inflammatory polyps and rectal bleeding clearly in clinical notes. Ensure the code K51.411 is used when both the polyps and bleeding are present. Verify that the underlying cause (e.g., ulcerative colitis) is documented separately if applicable, as coding depends on specific clinical details.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

K51.411 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.